secwatch.observer — SEC 8-K summary
======================================

Issuer:     CS DIAGNOSTICS CORP. (CSDX)
CIK:        0001106861
Form:       8-K
Filed at:   2025-10-31T23:59:59+00:00
Accession:  0001214659-25-015660
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CS Diagnostics completes conversion of Preferred B shares to 112.7M common shares; affiliates now hold common stock
--------------------------------------------------------------------------------

- Conversion of all Series B Preferred Stock held by affiliates CS Interpharm and CS Diagnostics Pharma into 112,652,000 common shares.
- Consolidates capital structure for consolidated financial reporting for FY ending Dec 31, 2025.
- Affiliates' resales of converted shares remain subject to Rule 144 volume and manner-of-sale restrictions.
- Benefits cited: enhanced transparency, improved efficiency, stronger alignment with common shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106861/000121465925015660/0001214659-25-015660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106861/000121465925015660/i10312518k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-25-015660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer